Comment
Time to reconsider how we do antibiotic therapy trials

https://doi.org/10.1016/S1473-3099(14)71063-1Get rights and content

References (10)

  • A Singanayagam et al.

    Epidemiology of CAP in Europe

    Eur Respir Monogr

    (2014)
  • T Welte et al.

    Clinical and economic burden of community-acquired pneumonia among adults in Europe

    Thorax

    (2012)
  • Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia

    Am J Respir Crit Care Med

    (2005)
  • JD Chalmers et al.

    Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis

    Clin Infect Dis

    (2014)
  • NS Zhong et al.

    Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial. Lancet Infect Dis; published online Dec 22

There are more references available in the full text version of this article.

Cited by (2)

View full text